NCT00805909View on ClinicalTrials.gov

NI-0401 in Patients With Acute Renal Allograft Rejection

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Acute Renal Transplant Rejection
Interventions
DRUG

NI-0401

5 daily infusions with escalating doses of NI-0401

Trial Locations (1)

75006

Hôpital Necker, Paris

Sponsors
All Listed Sponsors
lead

Light Chain Bioscience - Novimmune SA

INDUSTRY